News

The study is a randomized, crossover study evaluating formulations of insulin nasal spray as compared to NovoLog insulin aspart, an approved, rapid-acting injectable insulin, on post-meal glycemic control.

These data were generated from an analysis of the Phase III, randomized, controlled clinical trial that investigated the treatment effect of Vectibix in patients with metastatic colorectal cancer

WX-671 was administered in different doses to patients for 15 days before surgery. It was found to be safe and well tolerated at all dose levels tested. The

This recommendation is based on the safety analyses of data from thoracic subjects who have been treated at the 9mg dosage level and overall evaluation of safety of

The European Medicines Agency’s (EMEA) orphan medicinal product designation is designed to encourage sponsors in developing drugs, which may provide significant benefit to patients suffering from rare diseases

Compared to placebo, patients treated with APD125 experienced statistically significant improvements in measurements of sleep maintenance, or the ability to maintain sleep during the night after falling asleep.

Patient enrollment in this Phase I/IIa trial required stepwise enrollment by escalating dose cohort, with a pause for safety evaluation required after the last patient in the previous

A preliminary analysis of the study results demonstrated that it is safe and well-tolerated at the doses examined, and produced a statistically significant reduction in plasma triglyceride levels,

This pivotal trial will assess progression-free survival as the primary endpoint and overall survival as a secondary endpoint in patients with metastatic sarcomas following a favorable response to